More than 180 species of “magic” mushrooms produce the psychoactive compound psilocybin. When you ingest psilocybin, your gut converts it into another chemical called psilocin, which triggers changes in the brain. It increases activity in the visual cortex, leading to changes in perception; it decreases network activity in the “Default Mode Network,” driving the experience of ego loss; and it increases connectivity among different regions of the brain. Researchers believe it’s the combination of these effects that makes psilocybin an effective tool for combating depression and addiction, for which research shows support.
Recent Posts
- COVID-19: Some turning to psychedelic micro-dosing to cope with mental health stress, anxiety February 4, 2021
- The Scientific Difference Between LSD and Magic Mushrooms January 29, 2021
- LSD vs Psilocybin January 21, 2021
- The Case for Macrodosing – Shelby Hartman for Rolling Stone December 17, 2020
- Some doctors, therapists get Health Canada permission to use magic mushrooms December 14, 2020
- When To Microdose October 19, 2020
- Why Do Magic Mushrooms Cause “The Yawns”? August 31, 2020
- Therapsil: 4 Palliative Canadians approved for end of life psilocybin therapy through section 56(1) ; First legal medical exemptions for psilocybin in Canada since 1970’s August 4, 2020
- People who ‘microdose’ LSD and magic mushrooms score higher on measures of wisdom, open-mindedness and creativity July 24, 2020
- New psychedelic research sheds light on why psilocybin-containing mushrooms have been consumed for centuries July 21, 2020